In this prospective , randomized , investigator-masked , comparative clinical trial , patients with mild-to-moderate noninfectious AAU were assigned randomly to receive either hourly nonpreserved methylprednisolone 1 % ( group A ) or preserved prednisolone 1 % ( group B ) eye drops followed by a 2-week tapering regimen .